Teleost Biopharmceutical

Teleost is developing a skin care product representing a paradigm shift in the cosmeceutical, neutraceutal and pharmaceutical industries.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Tucson, AZ, US
  • Currency USD
  • Founded March 2014
  • Employees 1
  • Website http://teleostbio.com

Company Summary

The mission of Teleost is to help people project themselves from sun damage by stimulating melanin production in the body that does not need to be triggered by UV light. There are 2 routes for product development: 1) Seeking approval for a synthetic peptide through the FDA route and 2) Using the natural molecule and proceeding through the nutritional and cosmetic routes. We are currently pursuing a partnership with a global skin care company.

Advisors

  • Dr. Victor Hruby
    Chief Scientific Officer
    Unconfirmed
    Dr. Minying Cai
    Chief Research Scientist
    Unconfirmed
    Dr. Paul Eynott
    Licensing Manager for the University of Arizona
    Unconfirmed
  • Quan Nguyen, IP Attorney, Nguyen & Tarbet
    University of Arizona, Regents Approved, Intellectual Property Attorney
    Unconfirmed
    Lawrence Hecker, Attorney, Principal, Hecker & Muehlebach, PLLC
    Corporate Attorney
    Unconfirmed
    Dr. Peter Cogen
    Pharmacological Studies and Drug Design
    Unconfirmed
  • John Lauer, HBL CPAs, P.C.
    CPA/CFO
    Unconfirmed
    Chief Consultant
    Market Research Specialist

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free